Sort
48,018 grants matching “immunotherapy”
HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS
$619,283Tufts University Boston · R33 · FY2001 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$619,255Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$619,253Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Phase Changing Ultrasound Contrast Agents for Deep Tissue Imaging of Cellular Immunotherapies
$619,228Scott Hammond Medina · Pennsylvania State University, The · R01 · FY2025 · CA
Regulatory T cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$619,189Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U19 · FY2020 · AI
Regulatory T cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$619,188Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U19 · FY2021 · AI
T Cell Memory to Viruses
$619,172Rafi Ahmed · Emory University · R01 · FY2025 · AI
Facile Generation of Protein-Protein Conjugates Using Enzymatic Oxidative Coupling Reactions
$619,084Matthew B Francis · University Of California Berkeley · R01 · FY2025 · GM
Immunosuppressive mechanisms of intratumoral regulatory T cells
$618,928Michel Dupage · University Of California Berkeley · R01 · FY2025 · CA
Profiling the Fluid Assisted Dissemination of Pre-malignant cells in Fallopian Tubes
$618,886Geeta Mehta · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
$618,854Emese Zsiros · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
$618,825Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
LIGHTING-UP PROSTATE CANCER FOR IMMUNOTHERAPY
$618,750University Of Southern California · · FY2015 · Department of the Army
Immunologic Control of Drug-resistant HIV-1
$618,748University Of California San Francisco · R01 · FY2004 · AI
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
$618,713Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2023 · CA
Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer
$618,702Alejandro Gutierrez · Boston Children'S Hospital · R01 · FY2022 · CA
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells
$618,659Robbie B Mailliard · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Personalized Immunotherapy of Patients with Ovarian Cancer
$618,612Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
$618,579Frederic D Bushman · University Of Pennsylvania · R01 · FY2019 · CA
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
$618,498Robert J Gray · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$618,468Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Alternative MHCII Processing of Influenza Virus Proteins
$618,448Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2016 · AI
Mitonuclear Communication During the Pathogenesis of Inflammatory Bowel Disease
$618,405Kevin P Mollen · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis
$618,378Kevin Keewoun Kim · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$618,327Xiang Zhang · Baylor College Of Medicine · R01 · FY2020 · CA